Healthcare Sector Stocks
The Healthcare sector has a total of 1047 stocks, with a combined market cap of $9.08 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.20.
Market Cap
9.08T
Revenue
4.67T
Profits
188.35B
PE Ratio
48.20
Profit Margin
4.04%
Dividend Yield
0.39%
1045 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.00T | -0.11% | 1,994,325 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 641.88B | -0.27% | 4,927,256 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 450.61B | 1.63% | 4,396,902 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 357.02B | -1.91% | 7,547,081 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 348.52B | -1.22% | 4,346,051 | 450.53B |
| 6 | NVS | Novartis AG | 262.68B | - | 2,419,811 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 246.71B | 1.72% | 2,935,386 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 223.02B | -0.41% | 1,545,769 | 46.34B |
| 9 | AMGN | Amgen Inc. | 206.78B | -2.25% | 3,431,959 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 196.94B | -1.23% | 6,579,912 | 50.34B |
| 11 | GILD | Gilead Sciences, Inc. | 179.56B | -0.58% | 6,019,739 | 30.46B |
| 12 | ABT | Abbott Laboratories | 178.85B | -1.78% | 7,844,731 | 46.59B |
| 13 | PFE | Pfizer Inc. | 157.60B | -0.47% | 28,812,834 | 63.70B |
| 14 | DHR | Danaher Corporation | 140.97B | -2.11% | 3,021,071 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 130.42B | -1.26% | 815,172 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 130.22B | -1.02% | 6,526,685 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 127.34B | 2.04% | 3,369,710 | 11.03B |
| 18 | CVS | CVS Health Corporation | 121.87B | -0.09% | 3,877,979 | 412.65B |
| 19 | MDT | Medtronic plc | 117.19B | -0.29% | 5,119,208 | 37.54B |
| 20 | SYK | Stryker Corporation | 103.57B | -1.95% | 3,475,962 | 25.84B |
| 21 | MCK | McKesson Corporation | 102.70B | -1.21% | 852,968 | 410.98B |
| 22 | SNY | Sanofi | 102.49B | -0.30% | 1,959,805 | 55.89B |
| 23 | GSK | GSK plc | 96.24B | -1.05% | 2,151,047 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 91.19B | -0.15% | 1,408,145 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 90.33B | 5.41% | 1,904,060 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.21B | -1.78% | 524,564 | 15.53B |
| 27 | CI | The Cigna Group | 74.23B | 0.99% | 1,546,777 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 62.46B | -4.14% | 22,690,803 | 21.00B |
| 29 | ARGX | argenx SE | 62.23B | -1.82% | 226,406 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.25B | -0.73% | 1,346,330 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.64B | -0.55% | 1,749,237 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 54.89B | -1.66% | 1,216,426 | 254.25B |
| 33 | MRNA | Moderna, Inc. | 54.54B | 0.74% | 7,873,512 | 2.23B |
| 34 | EW | Edwards Lifesciences Corporation | 50.01B | 0.68% | 2,310,801 | 6.51B |
| 35 | HUM | Humana Inc. | 48.12B | 0.18% | 922,249 | 145.68B |
| 36 | BDX | Becton, Dickinson and Company | 48.05B | -1.88% | 1,705,003 | 22.48B |
| 37 | NTRA | Natera, Inc. | 47.01B | -1.26% | 1,070,011 | 2.71B |
| 38 | RVMD | Revolution Medicines, Inc. | 43.59B | -2.08% | 810,663 | - |
| 39 | MDLN | Medline Inc. | 42.58B | -4.88% | 7,325,062 | 29.94B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 42.36B | -1.36% | 4,014,360 | 17.32B |
| 41 | IQV | IQVIA Holdings Inc. | 42.35B | 0.12% | 1,319,968 | 16.98B |
| 42 | VEEV | Veeva Systems Inc. | 42.25B | 0.07% | 853,301 | 3.46B |
| 43 | A | Agilent Technologies, Inc. | 40.35B | -1.13% | 1,521,008 | 7.37B |
| 44 | HLN | Haleon plc | 40.06B | -0.11% | 16,741,002 | 14.80B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 39.90B | -1.67% | 422,339 | 4.55B |
| 46 | WAT | Waters Corporation | 39.46B | -0.78% | 572,735 | 4.64B |
| 47 | ONC | BeOne Medicines AG | 38.86B | -2.62% | 1,000,357 | 6.13B |
| 48 | RPRX | Royalty Pharma plc | 33.78B | -3.04% | 3,324,113 | 2.54B |
| 49 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.12B | -4.07% | 1,626,111 | 4.80B |
| 50 | ALC | Alcon Inc. | 32.47B | -2.75% | 1,573,409 | 10.86B |
| 51 | CNC | Centene Corporation | 32.31B | 2.09% | 4,627,897 | 180.30B |
| 52 | DXCM | DexCom, Inc. | 31.89B | 0.75% | 3,540,993 | 4.97B |
| 53 | BIIB | Biogen Inc. | 31.83B | 2.23% | 936,611 | 10.03B |
| 54 | RMD | ResMed Inc. | 31.41B | -0.17% | 923,142 | 5.65B |
| 55 | ILMN | Illumina, Inc. | 30.39B | -1.82% | 1,294,616 | 4.49B |
| 56 | ZTS | Zoetis Inc. | 30.11B | -0.61% | 5,409,744 | 9.53B |
| 57 | ROIV | Roivant Sciences Ltd. | 29.57B | -2.08% | 6,538,036 | 7.53M |
| 58 | GEHC | GE HealthCare Technologies Inc. | 29.02B | -1.43% | 3,121,611 | 21.27B |
| 59 | INSM | Insmed Incorporated | 27.80B | -1.18% | 2,594,777 | 1.14B |
| 60 | MTD | Mettler-Toledo International Inc. | 25.66B | -0.76% | 185,894 | 4.13B |
| 61 | DGX | Quest Diagnostics Incorporated | 25.51B | -1.83% | 1,090,524 | 11.56B |
| 62 | INCY | Incyte Corporation | 24.99B | -2.17% | 1,458,798 | 5.82B |
| 63 | LH | Labcorp Holdings Inc. | 24.89B | -4.40% | 1,254,418 | 14.35B |
| 64 | WST | West Pharmaceutical Services, Inc. | 24.23B | 2.17% | 653,058 | 3.33B |
| 65 | BNTX | BioNTech SE | 24.22B | -1.76% | 760,363 | 3.03B |
| 66 | PHG | Koninklijke Philips N.V. | 24.21B | -1.68% | 817,233 | 20.18B |
| 67 | UTHR | United Therapeutics Corporation | 21.61B | -0.58% | 653,155 | 3.15B |
| 68 | GH | Guardant Health, Inc. | 21.34B | -2.30% | 1,055,685 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 21.21B | -2.09% | 629,157 | 21.81B |
| 70 | STE | STERIS plc | 20.71B | -1.23% | 691,873 | 6.04B |
| 71 | GMAB | Genmab A/S | 19.36B | -2.45% | 1,015,755 | 4.13B |
| 72 | VTRS | Viatris Inc. | 18.81B | -0.73% | 9,008,438 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.63B | -2.29% | 1,365,921 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.16B | 0.16% | 499,018 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.28B | -0.54% | 195,542 | 2.78B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 15.92B | 0.92% | 895,198 | 3.37B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.61B | -0.34% | 1,029,483 | 4.60B |
| 78 | SOLV | Solventum Corporation | 14.92B | -2.64% | 709,696 | 8.31B |
| 79 | EXEL | Exelixis, Inc. | 14.23B | -1.54% | 1,628,980 | 2.44B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 14.17B | -4.71% | 3,042,769 | 713.07M |
| 81 | SMMT | Summit Therapeutics Inc. | 13.56B | -3.08% | 4,221,374 | - |
| 82 | RVTY | Revvity, Inc. | 13.50B | -2.35% | 1,344,112 | 2.91B |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.03B | -1.92% | 764,670 | 4.00B |
| 84 | ICLR | ICON Public Limited Company | 12.78B | 3.87% | 1,142,378 | 8.29B |
| 85 | BMRN | BioMarin Pharmaceutical Inc. | 12.68B | 1.71% | 2,202,726 | 3.41B |
| 86 | PEN | Penumbra, Inc. | 12.52B | -0.56% | 141,323 | 1.50B |
| 87 | BAX | Baxter International Inc. | 12.50B | -0.86% | 5,751,350 | 11.47B |
| 88 | CORT | Corcept Therapeutics Incorporated | 12.42B | -0.67% | 683,005 | 830.81M |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.32B | -2.48% | 225,763 | 1.28B |
| 90 | HALO | Halozyme Therapeutics, Inc. | 12.14B | -0.36% | 1,487,864 | 1.66B |
| 91 | BTSG | BrightSpring Health Services, Inc. | 12.06B | -6.63% | 3,317,147 | 14.37B |
| 92 | EHC | Encompass Health Corporation | 11.94B | -0.39% | 710,766 | 6.21B |
| 93 | FMS | Fresenius Medical Care AG | 11.86B | -0.45% | 459,878 | 22.19B |
| 94 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.69B | 0.16% | 1,003,172 | 669.50M |
| 95 | SNN | Smith & Nephew plc | 11.67B | -0.65% | 1,690,911 | 6.30B |
| 96 | DVA | DaVita Inc. | 11.56B | -0.92% | 565,279 | 14.01B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.42B | -2.93% | 5,633,883 | 5.02B |
| 98 | TECH | Bio-Techne Corporation | 11.30B | -0.24% | 3,769,435 | 1.22B |
| 99 | AXSM | Axsome Therapeutics, Inc. | 11.06B | 0.23% | 526,335 | 776.57M |
| 100 | ALGN | Align Technology, Inc. | 10.71B | -1.44% | 836,056 | 4.14B |
| 101 | TEM | Tempus AI, Inc. | 10.60B | -4.14% | 5,502,729 | 1.43B |
| 102 | MOH | Molina Healthcare, Inc. | 10.43B | 3.17% | 1,006,828 | 42.47B |
| 103 | COO | The Cooper Companies, Inc. | 10.30B | -14.67% | 18,654,433 | 4.24B |
| 104 | CYTK | Cytokinetics, Incorporated | 10.23B | -0.66% | 1,444,870 | 67.67M |
| 105 | KRYS | Krystal Biotech, Inc. | 10.23B | -0.73% | 175,770 | 440.48M |
| 106 | UHS | Universal Health Services, Inc. | 10.18B | -1.74% | 665,229 | 18.11B |
| 107 | ABVX | ABIVAX Société Anonyme | 10.17B | -2.94% | 1,289,298 | 5.67M |
| 108 | AVTR | Avantor, Inc. | 10.06B | - | 7,537,928 | 6.56B |
| 109 | OSCR | Oscar Health, Inc. | 10.05B | 2.58% | 4,114,313 | 15.32B |
| 110 | GKOS | Glaukos Corporation | 10.04B | -5.23% | 1,009,475 | 612.84M |
| 111 | ENSG | The Ensign Group, Inc. | 9.99B | 0.60% | 379,263 | 5.49B |
| 112 | RDY | Dr. Reddy's Laboratories Limited | 9.94B | -1.43% | 2,931,081 | 3.50B |
| 113 | GMED | Globus Medical, Inc. | 9.88B | -1.29% | 1,492,334 | 3.14B |
| 114 | BIO | Bio-Rad Laboratories, Inc. | 9.86B | -2.18% | 334,372 | 2.59B |
| 115 | HSIC | Henry Schein, Inc. | 9.73B | -0.76% | 1,536,371 | 13.60B |
| 116 | KYMR | Kymera Therapeutics, Inc. | 9.73B | 1.36% | 734,281 | 105.00M |
| 117 | PRAX | Praxis Precision Medicines, Inc. | 9.45B | -1.95% | 218,811 | 7.46M |
| 118 | PTGX | Protagonist Therapeutics, Inc. | 9.39B | 0.05% | 538,164 | 281.99M |
| 119 | PODD | Insulet Corporation | 9.34B | -2.35% | 1,866,848 | 3.05B |
| 120 | RGEN | Repligen Corporation | 9.29B | -0.22% | 950,291 | 785.10M |
| 121 | IONS | Ionis Pharmaceuticals, Inc. | 9.25B | -0.66% | 3,057,152 | 874.09M |
| 122 | PCVX | Vaxcyte, Inc. | 8.76B | -1.03% | 1,160,663 | - |
| 123 | QGEN | Qiagen N.V. | 8.71B | -0.87% | 1,246,264 | 2.10B |
| 124 | TXG | 10x Genomics, Inc. | 8.65B | -1.35% | 2,436,035 | 616.91M |
| 125 | IBRX | ImmunityBio, Inc. | 8.18B | -4.22% | 8,805,612 | 165.79M |
| 126 | BRKR | Bruker Corporation | 8.16B | -1.60% | 1,882,886 | 3.50B |
| 127 | TWST | Twist Bioscience Corporation | 7.95B | 1.06% | 1,284,817 | 431.80M |
| 128 | IMVT | Immunovant, Inc. | 7.87B | -1.68% | 1,083,362 | - |
| 129 | TGTX | TG Therapeutics, Inc. | 7.86B | 1.35% | 1,367,347 | 799.54M |
| 130 | ATR | AptarGroup, Inc. | 7.82B | 0.77% | 435,089 | 3.93B |
| 131 | SYRE | Spyre Therapeutics, Inc. | 7.82B | 2.05% | 902,256 | - |
| 132 | HQY | HealthEquity, Inc. | 7.82B | 2.04% | 685,095 | 1.36B |
| 133 | ALKS | Alkermes plc | 7.74B | 1.56% | 1,193,866 | 1.67B |
| 134 | HNGE | Hinge Health, Inc. | 7.12B | -3.34% | 2,423,590 | 720.06M |
| 135 | PACS | PACS Group, Inc. | 7.10B | 0.56% | 900,158 | 5.55B |
| 136 | BLTE | Belite Bio, Inc | 7.05B | -4.42% | 211,075 | - |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.04B | 1.13% | 422,883 | 239.92M |
| 138 | GRFS | Grifols, S.A. | 6.82B | -2.17% | 302,561 | 8.48B |
| 139 | CAI | Caris Life Sciences, Inc. | 6.79B | 0.04% | 2,629,133 | 989.61M |
| 140 | SRRK | Scholar Rock Holding Corporation | 6.78B | 1.92% | 1,175,623 | - |
| 141 | CHE | Chemed Corporation | 6.69B | -0.80% | 90,912 | 2.60B |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.55B | -0.31% | 613,153 | 1.56B |
| 143 | MIRM | Mirum Pharmaceuticals, Inc. | 6.53B | 2.35% | 587,034 | 618.07M |
| 144 | HIMS | Hims & Hers Health, Inc. | 6.40B | -1.65% | 7,567,125 | 2.58B |
| 145 | CGON | CG Oncology, Inc. | 6.38B | 0.06% | 657,929 | 6.23M |
| 146 | TVTX | Travere Therapeutics, Inc. | 6.36B | 1.95% | 1,559,497 | 591.33M |
| 147 | MMED | MiniMed Group, Inc. | 6.31B | -1.41% | 1,652,518 | 3.22B |
| 148 | BLCO | Bausch + Lomb Corporation | 6.27B | -1.35% | 521,447 | 5.32B |
| 149 | LQDA | Liquidia Corporation | 6.07B | -1.84% | 955,021 | 450.91M |
| 150 | ORKA | Oruka Therapeutics, Inc. | 6.07B | 0.16% | 554,604 | - |
| 151 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.97B | -2.60% | 459,651 | 840.85M |
| 152 | COGT | Cogent Biosciences, Inc. | 5.92B | -0.29% | 2,264,643 | - |
| 153 | AMRX | Amneal Pharmaceuticals, Inc. | 5.88B | -2.20% | 1,036,023 | 3.12B |
| 154 | RDNT | RadNet, Inc. | 5.85B | 4.81% | 801,847 | 2.27B |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 5.78B | -3.51% | 535,689 | 1.90M |
| 156 | LGND | Ligand Pharmaceuticals Incorporated | 5.77B | 0.42% | 146,530 | 290.54M |
| 157 | STVN | Stevanato Group S.p.A. | 5.72B | 3.51% | 279,116 | 1.40B |
| 158 | XENE | Xenon Pharmaceuticals Inc. | 5.69B | -0.31% | 797,627 | 7.50M |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.62B | -0.30% | 1,013,224 | 1.01B |
| 160 | ERAS | Erasca, Inc. | 5.61B | 2.10% | 8,250,026 | - |
| 161 | TFX | Teleflex Incorporated | 5.59B | -2.74% | 763,238 | 2.25B |
| 162 | SHC | Sotera Health Company | 5.21B | -0.38% | 1,747,116 | 1.22B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.16B | -0.83% | 549,942 | 1.58B |
| 164 | DFTX | Definium Therapeutics, Inc. | 5.07B | -0.68% | 1,404,306 | - |
| 165 | CRSP | CRISPR Therapeutics AG | 5.05B | -2.23% | 1,262,229 | 13.39M |
| 166 | LFST | LifeStance Health Group, Inc. | 4.97B | 3.01% | 5,941,392 | 1.58B |
| 167 | ACAD | ACADIA Pharmaceuticals Inc. | 4.78B | 0.22% | 1,014,508 | 1.14B |
| 168 | EWTX | Edgewise Therapeutics, Inc. | 4.66B | -1.13% | 788,443 | - |
| 169 | BLLN | BillionToOne, Inc. | 4.65B | -0.66% | 729,069 | 397.41M |
| 170 | HAE | Haemonetics Corporation | 4.60B | -2.04% | 602,320 | 1.35B |
| 171 | PBLS | Parabilis Medicines, Inc. | 4.49B | -6.30% | 680,761 | 148.00K |
| 172 | WAY | Waystar Holding Corp. | 4.42B | -3.35% | 959,016 | 1.21B |
| 173 | DOCS | Doximity, Inc. | 4.40B | 2.15% | 3,176,705 | 655.57M |
| 174 | CON | Concentra Group Holdings Parent, Inc. | 4.37B | 0.18% | 612,071 | 2.29B |
| 175 | LIVN | LivaNova PLC | 4.31B | -0.95% | 426,005 | 1.47B |
| 176 | ITGR | Integer Holdings Corporation | 4.28B | 0.15% | 554,462 | 1.84B |
| 177 | CELC | Celcuity Inc. | 4.18B | -5.10% | 1,069,432 | - |
| 178 | NVST | Envista Holdings Corporation | 4.16B | -2.08% | 2,218,374 | 2.86B |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.14B | 1.23% | 3,000,710 | 10.35M |
| 180 | ELVN | Enliven Therapeutics, Inc. | 4.12B | -2.12% | 769,638 | - |
| 181 | MANE | Veradermics, Incorporated | 4.10B | -1.54% | 394,444 | - |
| 182 | TLX | Telix Pharmaceuticals Limited | 4.08B | -3.57% | 337,790 | 890.79M |
| 183 | INDV | Indivior Pharmaceuticals, Inc. | 4.07B | -0.75% | 1,319,647 | 1.33B |
| 184 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.03B | -0.96% | 1,670,385 | -665.00K |
| 185 | HTFL | HeartFlow, Inc. | 3.96B | -2.53% | 2,256,879 | 212.07M |
| 186 | TNGX | Tango Therapeutics, Inc. | 3.94B | -2.62% | 3,437,311 | 53.81M |
| 187 | ICUI | ICU Medical, Inc. | 3.93B | -2.32% | 162,819 | 2.16B |
| 188 | PLSE | Pulse Biosciences, Inc. | 3.88B | 2.76% | 915,394 | 1.19M |
| 189 | ADPT | Adaptive Biotechnologies Corporation | 3.87B | -0.78% | 1,071,429 | 308.08M |
| 190 | VKTX | Viking Therapeutics, Inc. | 3.75B | -1.74% | 1,715,157 | - |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.72B | -5.60% | 727,281 | 825.34M |
| 192 | LEGN | Legend Biotech Corporation | 3.72B | -3.62% | 1,824,338 | 1.27B |
| 193 | IOVA | Iovance Biotherapeutics, Inc. | 3.69B | -3.44% | 10,570,374 | 324.97M |
| 194 | IDYA | IDEAYA Biosciences, Inc. | 3.61B | -2.35% | 547,790 | 234.13M |
| 195 | OGN | Organon & Co. | 3.58B | -0.29% | 2,082,225 | 6.13B |
| 196 | TARS | Tarsus Pharmaceuticals, Inc. | 3.56B | -1.99% | 403,271 | 606.33M |
| 197 | OPCH | Option Care Health, Inc. | 3.54B | -0.04% | 1,575,090 | 5.69B |
| 198 | NHC | National HealthCare Corporation | 3.52B | -1.02% | 75,465 | 1.56B |
| 199 | GRAL | GRAIL, Inc. | 3.46B | 0.10% | 896,949 | 165.26M |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.44B | -4.01% | 4,709,977 | - |
| 201 | DNLI | Denali Therapeutics Inc. | 3.42B | -0.79% | 938,544 | 3.60M |
| 202 | ABCL | AbCellera Biologics Inc. | 3.39B | -5.34% | 4,944,599 | 66.17M |
| 203 | VCYT | Veracyte, Inc. | 3.38B | -4.17% | 849,382 | 561.90M |
| 204 | RCUS | Arcus Biosciences, Inc. | 3.33B | -8.21% | 2,391,092 | 117.00M |
| 205 | QURE | uniQure N.V. | 3.08B | -3.33% | 867,400 | 18.67M |
| 206 | AVAH | Aveanna Healthcare Holdings Inc. | 3.02B | -1.14% | 3,918,544 | 2.60B |
| 207 | WRBY | Warby Parker Inc. | 3.00B | -1.10% | 2,322,335 | 911.61M |
| 208 | CLDX | Celldex Therapeutics, Inc. | 2.99B | -1.75% | 948,880 | 158.00K |
| 209 | TMDX | TransMedics Group, Inc. | 2.95B | -1.57% | 591,605 | 668.47M |
| 210 | ARQT | Arcutis Biotherapeutics, Inc. | 2.94B | -1.93% | 1,785,455 | 463.98M |
| 211 | MBX | MBX Biosciences, Inc. | 2.93B | -3.13% | 457,257 | - |
| 212 | BKD | Brookdale Senior Living Inc. | 2.91B | 0.49% | 5,569,505 | 2.93B |
| 213 | IRON | Disc Medicine, Inc. | 2.85B | -3.10% | 480,865 | - |
| 214 | IMNM | Immunome, Inc. | 2.84B | -4.40% | 729,801 | 4.02M |
| 215 | GPCR | Structure Therapeutics Inc. | 2.82B | -4.07% | 761,358 | - |
| 216 | RGC | Regencell Bioscience Holdings Limited | 2.79B | -3.68% | 202,977 | - |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.78B | 1.01% | 698,574 | 1.46B |
| 218 | ATAI | AtaiBeckley Inc. | 2.73B | 0.82% | 9,587,449 | 4.47M |
| 219 | SLS | SELLAS Life Sciences Group, Inc. | 2.72B | -3.30% | 4,829,710 | - |
| 220 | ZLAB | Zai Lab Limited | 2.71B | -3.63% | 1,610,067 | 449.61M |
| 221 | ATRC | AtriCure, Inc. | 2.69B | -0.13% | 961,945 | 569.62M |
| 222 | NRIX | Nurix Therapeutics, Inc. | 2.68B | -1.71% | 1,029,475 | 36.77M |
| 223 | ACHC | Acadia Healthcare Company, Inc. | 2.66B | 1.21% | 1,087,976 | 3.37B |
| 224 | ALHC | Alignment Healthcare, Inc. | 2.65B | -2.07% | 4,962,157 | 4.58B |
| 225 | PHVS | Pharvaris N.V. | 2.63B | -0.61% | 1,324,858 | - |
| 226 | NAMS | NewAmsterdam Pharma Company N.V. | 2.61B | -4.08% | 2,728,691 | 7.12M |
| 227 | PRVA | Privia Health Group, Inc. | 2.60B | -0.24% | 1,263,425 | 2.36B |
| 228 | MLYS | Mineralys Therapeutics, Inc. | 2.59B | -3.93% | 763,754 | - |
| 229 | CDNA | CareDx, Inc. | 2.59B | -0.02% | 1,606,739 | 458.09M |
| 230 | NEOG | Neogen Corporation | 2.57B | -1.26% | 1,956,189 | 870.40M |
| 231 | VRDN | Viridian Therapeutics, Inc. | 2.53B | -1.94% | 1,310,066 | 71.13M |
| 232 | WGS | GeneDx Holdings Corp. | 2.50B | -2.91% | 711,562 | 454.43M |
| 233 | CLOV | Clover Health Investments, Corp. | 2.50B | 8.53% | 6,707,140 | 2.48B |
| 234 | BEAM | Beam Therapeutics Inc. | 2.44B | -3.22% | 1,980,337 | 156.04M |
| 235 | SUPN | Supernus Pharmaceuticals, Inc. | 2.42B | -0.90% | 726,748 | 830.44M |
| 236 | VERA | Vera Therapeutics, Inc. | 2.42B | -0.53% | 2,027,441 | - |
| 237 | NKTR | Nektar Therapeutics | 2.41B | -3.64% | 946,511 | 54.59M |
| 238 | HRMY | Harmony Biosciences Holdings, Inc. | 2.39B | -1.25% | 736,797 | 959.90M |
| 239 | PGEN | Precigen, Inc. | 2.39B | -1.76% | 2,838,486 | 85.72M |
| 240 | HCM | HUTCHMED (China) Limited | 2.35B | -3.32% | 45,152 | 549.12M |
| 241 | OCUL | Ocular Therapeutix, Inc. | 2.33B | -7.41% | 2,391,644 | 52.06M |
| 242 | BHC | Bausch Health Companies Inc. | 2.27B | -1.46% | 1,591,688 | 10.85B |
| 243 | TRVI | Trevi Therapeutics, Inc. | 2.27B | -4.39% | 1,249,973 | - |
| 244 | NEO | NeoGenomics, Inc. | 2.26B | -0.28% | 1,111,694 | 766.30M |
| 245 | AXGN | Axogen, Inc. | 2.25B | -11.47% | 3,792,442 | 251.17M |
| 246 | PBH | Prestige Consumer Healthcare Inc. | 2.24B | -2.79% | 513,590 | 1.10B |
| 247 | NUVB | Nuvation Bio Inc. | 2.21B | -3.68% | 9,286,685 | 169.90M |
| 248 | TRLV | Trulieve Cannabis Corp. | 2.18B | -3.82% | 1,894,141 | 1.14B |
| 249 | ADUS | Addus HomeCare Corporation | 2.17B | -0.60% | 177,576 | 1.48B |
| 250 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | -6.81% | 2,204,221 | 1.97B |
| 251 | PVLA | Palvella Therapeutics, Inc. | 2.17B | -0.63% | 266,069 | - |
| 252 | UFPT | UFP Technologies, Inc. | 2.15B | -0.43% | 91,401 | 631.64M |
| 253 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -0.86% | 687,400 | 311.51M |
| 254 | ESTA | Establishment Labs Holdings Inc. | 2.13B | -4.19% | 267,740 | 245.82M |
| 255 | MD | Pediatrix Medical Group, Inc. | 2.12B | -1.33% | 740,579 | 1.95B |
| 256 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.12B | -5.85% | 9,001,376 | 940.61M |
| 257 | ADMA | ADMA Biologics, Inc. | 2.10B | -0.63% | 2,830,990 | 512.28M |
| 258 | XRAY | DENTSPLY SIRONA Inc. | 2.09B | -2.05% | 3,452,566 | 3.64B |
| 259 | RAPP | Rapport Therapeutics, Inc. | 2.09B | -0.98% | 319,261 | 20.00M |
| 260 | PGNY | Progyny, Inc. | 2.08B | -0.15% | 894,477 | 1.31B |
| 261 | URGN | UroGen Pharma Ltd. | 2.06B | -6.13% | 688,661 | 188.73M |
| 262 | KOD | Kodiak Sciences Inc. | 2.06B | -2.69% | 668,183 | - |
| 263 | ZBIO | Zenas BioPharma, Inc. | 2.03B | -3.69% | 646,937 | 1.00M |
| 264 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | -2.86% | 720,218 | 98.34M |
| 265 | MESO | Mesoblast Limited | 2.00B | -3.97% | 182,069 | 120.25M |
| 266 | GENB | Generate Biomedicines, Inc. | 1.98B | -0.84% | 1,008,446 | 26.48M |
| 267 | INSP | Inspire Medical Systems, Inc. | 1.97B | 2.47% | 1,136,572 | 898.74M |
| 268 | CMPS | COMPASS Pathways plc | 1.97B | -6.26% | 3,322,122 | - |
| 269 | ASTH | Astrana Health, Inc. | 1.95B | -0.08% | 264,192 | 3.84B |
| 270 | VCEL | Vericel Corporation | 1.94B | -2.87% | 340,231 | 306.30M |
| 271 | KLRA | Kailera Therapeutics, Inc. | 1.93B | 0.47% | 661,591 | - |
| 272 | BHVN | Biohaven Ltd. | 1.93B | -14.73% | 8,322,092 | - |
| 273 | ALMR | Alamar Biosciences, Inc. | 1.93B | -4.11% | 339,997 | 100.42M |
| 274 | BFLY | Butterfly Network, Inc. | 1.90B | -4.56% | 3,167,829 | 112.14M |
| 275 | STOK | Stoke Therapeutics, Inc. | 1.89B | -1.94% | 421,290 | 27.59M |
| 276 | PRGO | Perrigo Company plc | 1.89B | -5.23% | 1,982,938 | 4.14B |
| 277 | SNDA | Sonida Senior Living, Inc. | 1.88B | 0.53% | 391,998 | 481.07M |
| 278 | ZYME | Zymeworks Inc. | 1.88B | -2.63% | 585,282 | 37.13M |
| 279 | GHRS | GH Research PLC | 1.87B | -1.02% | 128,796 | - |
| 280 | ALVO | Alvotech | 1.87B | 0.58% | 540,848 | 494.61M |
| 281 | COAG | Hemab Therapeutics Holdings, Inc. | 1.86B | -10.38% | 433,563 | - |
| 282 | NBTX | Nanobiotix S.A. | 1.85B | 2.62% | 200,135 | 38.27M |
| 283 | SGRY | Surgery Partners, Inc. | 1.83B | - | 3,275,261 | 3.37B |
| 284 | XNCR | Xencor, Inc. | 1.80B | -2.73% | 1,360,856 | 104.97M |
| 285 | LMAT | LeMaitre Vascular, Inc. | 1.80B | -0.84% | 284,200 | 262.43M |
| 286 | VIR | Vir Biotechnology, Inc. | 1.79B | -2.13% | 1,855,255 | 303.23M |
| 287 | NVCR | NovoCure Limited | 1.79B | -1.79% | 1,385,207 | 699.19M |
| 288 | SEPN | Septerna, Inc. | 1.76B | -0.58% | 338,677 | 98.88M |
| 289 | LKFT | Lakefront Biotherapeutics NV | 1.76B | -2.26% | 170,022 | 1.13B |
| 290 | BRVE | Braveheart Bio, Inc. | 1.75B | -5.74% | 285,991 | - |
| 291 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.75B | -3.17% | 3,324,984 | 208.78M |
| 292 | KARD | Kardigan, Inc. | 1.75B | -5.03% | 432,965 | - |
| 293 | PSNL | Personalis, Inc. | 1.74B | -0.43% | 2,296,660 | 69.67M |
| 294 | IMCR | Immunocore Holdings plc | 1.73B | -2.58% | 221,769 | 430.78M |
| 295 | BLFS | BioLife Solutions, Inc. | 1.71B | -0.03% | 1,361,516 | 106.69M |
| 296 | RXRX | Recursion Pharmaceuticals, Inc. | 1.69B | -1.71% | 10,625,794 | 54.86M |
| 297 | TSHA | Taysha Gene Therapies, Inc. | 1.68B | -3.37% | 2,402,772 | 5.49M |
| 298 | SNDX | Syndax Pharmaceuticals, Inc. | 1.68B | -5.14% | 1,651,642 | 252.25M |
| 299 | NTLA | Intellia Therapeutics, Inc. | 1.67B | -2.29% | 3,924,870 | 59.51M |
| 300 | DMRA | Damora Therapeutics, Inc. | 1.66B | 2.17% | 639,516 | - |
| 301 | ETON | Eton Pharmaceuticals, Inc. | 1.65B | -1.61% | 281,696 | 105.60M |
| 302 | INBX | Inhibrx Biosciences, Inc. | 1.64B | -1.28% | 313,807 | 1.30M |
| 303 | ANAB | AnaptysBio, Inc. | 1.63B | -0.97% | 300,129 | 232.39M |
| 304 | FTRE | Fortrea Holdings Inc. | 1.62B | 1.37% | 741,126 | 2.68B |
| 305 | FRNM | Freenome, Inc. | 1.59B | -6.10% | 744,541 | 35.41M |
| 306 | AGL | agilon health, inc. | 1.55B | -1.06% | 254,922 | 5.92B |
| 307 | ARDT | Ardent Health, Inc. | 1.54B | -2.24% | 501,937 | 6.41B |
| 308 | AVLN | Avalyn Pharma Inc. | 1.54B | -3.37% | 129,052 | - |
| 309 | NVAX | Novavax, Inc. | 1.53B | -5.58% | 5,893,317 | 413.80M |
| 310 | ANIP | ANI Pharmaceuticals, Inc. | 1.53B | 1.07% | 228,885 | 978.38M |
| 311 | AAPG | Ascentage Pharma Group International | 1.53B | -3.70% | 3,079 | 94.61M |
| 312 | BCAX | Bicara Therapeutics Inc. | 1.53B | -2.28% | 644,774 | - |
| 313 | HCSG | Healthcare Services Group, Inc. | 1.50B | -0.86% | 392,605 | 1.86B |
| 314 | LBRX | LB Pharmaceuticals Inc | 1.49B | -2.98% | 174,758 | - |
| 315 | INVA | Innoviva, Inc. | 1.49B | -2.41% | 836,377 | 440.00M |
| 316 | APMD | Apnimed, Inc. | 1.49B | -4.56% | 213,418 | 120.15M |
| 317 | PAHC | Phibro Animal Health Corporation | 1.49B | -0.60% | 174,046 | 1.52B |
| 318 | OMCL | Omnicell, Inc. | 1.47B | -4.13% | 534,275 | 1.25B |
| 319 | INNV | InnovAge Holding Corp. | 1.45B | -3.90% | 286,602 | 989.71M |
| 320 | LTGO | Latigo Biotherapeutics, Inc. | 1.43B | -5.53% | 177,748 | - |
| 321 | RARE | Ultragenyx Pharmaceutical Inc. | 1.42B | 0.63% | 3,665,257 | 717.00M |
| 322 | AVBP | ArriVent BioPharma, Inc. | 1.42B | -3.66% | 564,160 | - |
| 323 | ABSI | Absci Corporation | 1.41B | -4.74% | 3,089,327 | 1.56M |
| 324 | SDGR | Schrödinger, Inc. | 1.41B | -2.08% | 512,007 | 259.04M |
| 325 | TYRA | Tyra Biosciences, Inc. | 1.40B | 6.95% | 2,477,505 | - |
| 326 | XERS | Xeris Biopharma Holdings, Inc. | 1.40B | -0.52% | 1,955,012 | 335.41M |
| 327 | CNMD | CONMED Corporation | 1.38B | -1.51% | 240,827 | 1.37B |
| 328 | KMTS | Kestra Medical Technologies, Ltd. | 1.38B | -2.08% | 310,493 | 95.13M |
| 329 | MAZE | Maze Therapeutics, Inc. | 1.38B | 0.98% | 1,181,274 | 20.00M |
| 330 | PNTG | The Pennant Group, Inc. | 1.37B | -0.76% | 215,324 | 1.10B |
| 331 | HROW | Harrow, Inc. | 1.37B | -2.58% | 371,106 | 275.59M |
| 332 | ATEC | Alphatec Holdings, Inc. | 1.37B | -1.67% | 2,381,423 | 815.05M |
| 333 | TRAX | First Tracks Biotherapeutics, Inc. | 1.36B | -4.02% | 389,069 | - |
| 334 | SVRA | Savara Inc. | 1.35B | -1.85% | 1,525,355 | - |
| 335 | CGEM | Cullinan Therapeutics, Inc. | 1.35B | -1.45% | 805,638 | - |
| 336 | OMER | Omeros Corporation | 1.35B | -4.13% | 1,231,840 | 38.42M |
| 337 | NUTX | Nutex Health Inc. | 1.34B | -1.25% | 90,525 | 846.72M |
| 338 | DRTS | Alpha Tau Medical Ltd. | 1.33B | 1.19% | 457,154 | - |
| 339 | AKTS | Aktis Oncology, Inc. | 1.33B | -0.50% | 263,616 | 10.06M |
| 340 | AZTA | Azenta, Inc. | 1.32B | 0.10% | 853,744 | 613.81M |
| 341 | VOR | Vor Biopharma Inc. | 1.32B | -3.87% | 691,997 | - |
| 342 | OMDA | Omada Health, Inc. | 1.32B | - | 1,157,229 | 309.76M |
| 343 | ALMS | Alumis Inc. | 1.28B | 1.02% | 4,732,149 | 7.40M |
| 344 | AMN | AMN Healthcare Services, Inc. | 1.28B | -3.81% | 667,417 | 3.43B |
| 345 | TNDM | Tandem Diabetes Care, Inc. | 1.27B | -4.19% | 1,589,501 | 1.04B |
| 346 | ORIC | ORIC Pharmaceuticals, Inc. | 1.25B | -3.44% | 1,025,283 | - |
| 347 | REPL | Replimune Group, Inc. | 1.25B | -8.37% | 3,646,336 | - |
| 348 | SPTX | Seaport Therapeutics, Inc. | 1.25B | 7.03% | 144,714 | - |
| 349 | ANRO | Alto Neuroscience, Inc. | 1.24B | -7.01% | 790,033 | - |
| 350 | MGTX | MeiraGTx Holdings plc | 1.23B | -3.09% | 716,510 | 397.50M |
| 351 | GLUE | Monte Rosa Therapeutics, Inc. | 1.22B | 0.42% | 1,064,520 | 28.73M |
| 352 | MNKD | MannKind Corporation | 1.22B | -3.81% | 3,209,523 | 393.63M |
| 353 | JBIO | Jade Biosciences, Inc. | 1.22B | 0.42% | 1,224,852 | - |
| 354 | IART | Integra LifeSciences Holdings Corporation | 1.21B | -4.37% | 1,325,180 | 1.65B |
| 355 | AORT | Artivion, Inc. | 1.20B | -2.26% | 694,540 | 471.47M |
| 356 | SLBT | SL Science Holding Limited | 1.20B | -19.54% | 278,617 | 3.27M |
| 357 | IMTX | Immatics N.V. | 1.20B | -3.95% | 798,732 | 47.65M |
| 358 | STAA | STAAR Surgical Company | 1.17B | -0.85% | 680,982 | 339.59M |
| 359 | CRON | Cronos Group Inc. | 1.17B | 0.16% | 584,094 | 179.09M |
| 360 | USPH | U.S. Physical Therapy, Inc. | 1.16B | -0.21% | 115,773 | 804.27M |
| 361 | PRCT | PROCEPT BioRobotics Corporation | 1.15B | -3.23% | 975,526 | 337.34M |
| 362 | GDRX | GoodRx Holdings, Inc. | 1.14B | 0.30% | 971,629 | 785.23M |
| 363 | ODTX | Odyssey Therapeutics, Inc. | 1.13B | -3.55% | 192,639 | 99.00K |
| 364 | CERT | Certara, Inc. | 1.13B | -2.75% | 2,255,172 | 421.75M |
| 365 | MLTX | MoonLake Immunotherapeutics | 1.12B | -3.94% | 1,221,530 | - |
| 366 | OPK | OPKO Health, Inc. | 1.11B | -3.25% | 1,449,013 | 587.90M |
| 367 | TDOC | Teladoc Health, Inc. | 1.11B | -0.16% | 2,519,160 | 2.49B |
| 368 | BVS | Bioventus Inc. | 1.10B | -4.18% | 528,090 | 581.85M |
| 369 | CRVS | Corvus Pharmaceuticals, Inc. | 1.09B | -2.93% | 1,094,669 | - |
| 370 | JANX | Janux Therapeutics, Inc. | 1.08B | -8.54% | 980,159 | 24.00M |
| 371 | LMRI | Lumexa Imaging Holdings, Inc. | 1.08B | -0.80% | 222,027 | 1.04B |
| 372 | ENOV | Enovis Corporation | 1.06B | -3.26% | 1,762,590 | 2.30B |
| 373 | OBX | Obsidian Therapeutics, Inc. | 1.06B | -8.14% | 454,194 | - |
| 374 | IRMD | IRADIMED CORPORATION | 1.05B | -2.02% | 120,198 | 86.34M |
| 375 | KURA | Kura Oncology, Inc. | 1.03B | -4.30% | 1,814,433 | 77.23M |
| 376 | ATTO | Attovia Therapeutics, Inc. | 1.03B | -1.44% | 190,017 | 1.80M |
| 377 | ABUS | Arbutus Biopharma Corporation | 1.01B | -0.97% | 2,449,363 | 181.72M |
| 378 | IVA | Inventiva S.A. | 1.01B | -6.97% | 808,180 | 7.94M |
| 379 | FTH | Faeth Therapeutics, Inc. | 1.01B | 7.97% | 445,385 | - |
| 380 | PCRX | Pacira BioSciences, Inc. | 1.00B | -2.78% | 733,768 | 746.16M |
| 381 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.00B | 2.17% | 514,987 | 730.02M |
| 382 | CSTL | Castle Biosciences, Inc. | 987.36M | 0.03% | 237,824 | 357.28M |
| 383 | SLDB | Solid Biosciences Inc. | 972.53M | -4.93% | 855,915 | - |
| 384 | ANL | Adlai Nortye Group Ltd. | 971.76M | 2.65% | 318,221 | 18.06M |
| 385 | GMRS | GMR Solutions Inc. | 969.19M | -4.66% | 492,968 | 5.88B |
| 386 | HELP | Cybin Inc. | 938.09M | -6.14% | 1,750,695 | - |
| 387 | OLMA | Olema Pharmaceuticals, Inc. | 935.35M | 3.19% | 1,116,380 | - |
| 388 | DSGN | Design Therapeutics, Inc. | 926.21M | -1.46% | 652,987 | - |
| 389 | SANA | Sana Biotechnology, Inc. | 925.02M | -2.52% | 4,617,532 | - |
| 390 | AVTX | Avalo Therapeutics, Inc. | 921.36M | -5.66% | 913,732 | 59.00K |
| 391 | WVE | Wave Life Sciences, Inc. | 920.21M | -2.91% | 2,767,715 | 65.37M |
| 392 | SGP | SpyGlass Pharma, Inc. | 913.46M | -0.69% | 83,606 | - |
| 393 | IMMX | Immix Biopharma, Inc. | 908.55M | 3.17% | 1,656,272 | - |
| 394 | ARDX | Ardelyx, Inc. | 902.06M | -4.74% | 4,047,355 | 450.89M |
| 395 | CBLL | CeriBell, Inc. | 899.20M | -4.01% | 220,125 | 101.96M |
| 396 | LXRX | Lexicon Pharmaceuticals, Inc. | 898.81M | -6.05% | 2,938,740 | 41.47M |
| 397 | TBPH | Theravance Biopharma, Inc. | 883.66M | -0.23% | 333,929 | 104.31M |
| 398 | RIGL | Rigel Pharmaceuticals, Inc. | 883.18M | 0.13% | 131,323 | 276.79M |
| 399 | GERN | Geron Corporation | 880.19M | -2.14% | 7,694,352 | 204.56M |
| 400 | CADL | Candel Therapeutics, Inc. | 866.96M | -6.90% | 1,952,924 | - |
| 401 | CLYM | Climb Bio, Inc. | 858.67M | -0.66% | 1,494,638 | - |
| 402 | INMD | InMode Ltd. | 848.99M | -0.14% | 824,972 | 374.63M |
| 403 | HSTM | HealthStream, Inc. | 844.45M | 0.73% | 195,496 | 321.12M |
| 404 | QDEL | QuidelOrtho Corporation | 833.19M | -3.88% | 1,175,719 | 2.67B |
| 405 | CBIO | Crescent Biopharma, Inc. | 832.91M | -2.65% | 233,133 | 11.88M |
| 406 | SIBN | SI-BONE, Inc. | 820.18M | -0.60% | 685,966 | 213.60M |
| 407 | ACRS | Aclaris Therapeutics, Inc. | 810.33M | -0.99% | 2,210,523 | 8.22M |
| 408 | AVR | Anteris Technologies Global Corp. | 808.91M | -2.70% | 842,347 | 2.24M |
| 409 | SLN | Silence Therapeutics plc | 801.39M | -1.77% | 682,631 | 615.00K |
| 410 | ANNX | Annexon, Inc. | 784.86M | -5.26% | 4,204,343 | - |
| 411 | AHCO | AdaptHealth Corp. | 780.44M | 2.63% | 3,225,863 | 3.36B |
| 412 | DBVT | DBV Technologies S.A. | 779.01M | -3.50% | 125,340 | 5.04M |
| 413 | VREX | Varex Imaging Corporation | 778.47M | -0.16% | 526,739 | 865.00M |
| 414 | MPLT | MapLight Therapeutics, Inc. | 766.11M | 0.55% | 490,308 | - |
| 415 | PHAR | Pharming Group N.V. | 760.78M | -1.50% | 15,338 | 366.48M |
| 416 | GLAS | Glass House Brands Inc. | 752.06M | -1.97% | 457,246 | 176.98M |
| 417 | ACHV | Achieve Life Sciences, Inc. | 749.13M | -3.45% | 2,476,146 | - |
| 418 | BBNX | Beta Bionics, Inc. | 746.38M | -4.76% | 957,709 | 119.01M |
| 419 | COLL | Collegium Pharmaceutical, Inc. | 746.17M | -1.88% | 889,094 | 808.21M |
| 420 | FDMT | 4D Molecular Therapeutics, Inc. | 745.24M | -4.87% | 566,241 | 92.01M |
| 421 | MNPR | Monopar Therapeutics Inc. | 738.07M | -2.15% | 94,154 | - |
| 422 | NVCT | Nuvectis Pharma, Inc. | 732.76M | -1.27% | 107,045 | - |
| 423 | CTMX | CytomX Therapeutics, Inc. | 729.96M | -5.37% | 2,058,651 | 18.30M |
| 424 | AURA | Aura Biosciences, Inc. | 724.90M | -2.92% | 785,533 | - |
| 425 | NGNE | Neurogene Inc. | 722.81M | -4.65% | 176,904 | 925.00K |
| 426 | ZVRA | Zevra Therapeutics, Inc. | 716.17M | 0.17% | 675,474 | 136.07M |
| 427 | GYRE | Gyre Therapeutics, Inc. | 714.67M | -3.02% | 83,101 | 109.82M |
| 428 | OCS | Oculis Holding AG | 698.19M | -1.39% | 169,235 | 1.45M |
| 429 | VSTM | Verastem, Inc. | 690.09M | -4.03% | 2,669,900 | 87.53M |
| 430 | SGMT | Sagimet Biosciences Inc. | 687.47M | 1.84% | 937,667 | - |
| 431 | AGMB | AgomAb Therapeutics NV | 686.52M | -6.82% | 106,721 | - |
| 432 | MDXG | MiMedx Group, Inc. | 670.50M | -1.71% | 1,622,124 | 355.17M |
| 433 | PHAT | Phathom Pharmaceuticals, Inc. | 664.83M | -3.46% | 1,092,470 | 239.66M |
| 434 | SSII | SS Innovations International, Inc. | 661.27M | 2.48% | 83,234 | 52.40M |
| 435 | BLSM | BlossomHill Therapeutics, Inc. | 659.15M | -2.23% | 158,850 | - |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 656.00M | -2.46% | 1,174,302 | 389.32M |
| 437 | SOPH | SOPHiA GENETICS SA | 647.82M | -0.91% | 378,522 | 86.17M |
| 438 | ALT | Altimmune, Inc. | 639.96M | -1.79% | 2,563,020 | 31.00K |
| 439 | VALN | Valneva SE | 638.85M | 0.15% | 46,538 | 163.30M |
| 440 | DRUG | Bright Minds Biosciences Inc. | 633.24M | -0.09% | 86,706 | - |
| 441 | STLN | Starling Oncology, Inc. | 631.88M | -1.43% | 679,967 | 587.24M |
| 442 | PHR | Phreesia, Inc. | 631.26M | -1.64% | 556,565 | 507.79M |
| 443 | ANGO | AngioDynamics, Inc. | 629.91M | -0.52% | 238,744 | 320.17M |
| 444 | EVO | Evotec SE | 629.15M | -2.21% | 23,943 | 819.47M |
| 445 | AQST | Aquestive Therapeutics, Inc. | 626.30M | -3.11% | 3,284,182 | 54.09M |
| 446 | AHG | Akso Health Group | 625.57M | -8.74% | 125,755 | 13.83M |
| 447 | CTEV | Claritev Corporation | 622.65M | 1.24% | 82,879 | 994.67M |
| 448 | CRMD | CorMedix Inc. | 620.44M | -2.09% | 857,218 | 462.25M |
| 449 | ASMB | Assembly Biosciences, Inc. | 620.18M | -7.33% | 348,593 | 74.85M |
| 450 | STTK | Shattuck Labs, Inc. | 617.23M | -2.84% | 1,171,958 | 1.00M |
| 451 | ALLO | Allogene Therapeutics, Inc. | 608.06M | 1.73% | 5,400,891 | 4.64M |
| 452 | PRME | Prime Medicine, Inc. | 595.98M | -3.46% | 2,390,206 | 4.07M |
| 453 | CTKB | Cytek Biosciences, Inc. | 588.82M | -4.23% | 2,417,078 | 206.71M |
| 454 | WEAV | Weave Communications, Inc. | 583.99M | - | 2,014,278 | 257.79M |
| 455 | OABI | OmniAb, Inc. | 574.29M | -1.62% | 1,393,742 | 38.46M |
| 456 | ARVN | Arvinas, Inc. | 569.51M | -0.57% | 776,723 | 316.70M |
| 457 | TLRY | Tilray Brands, Inc. | 567.15M | -1.66% | 2,971,877 | 915.45M |
| 458 | RGNX | REGENXBIO Inc. | 565.07M | -1.95% | 1,101,032 | 174.48M |
| 459 | KIDS | OrthoPediatrics Corp. | 562.93M | -0.55% | 492,210 | 252.72M |
| 460 | BWAY | BrainsWay Ltd. | 562.17M | -3.47% | 137,083 | 60.70M |
| 461 | TECX | Tectonic Therapeutic, Inc. | 559.31M | -6.14% | 252,387 | - |
| 462 | SCTX | Scribe Therapeutics Inc. | 557.92M | 0.20% | 189,431 | 33.30M |
| 463 | PROK | ProKidney Corp. | 556.27M | -0.54% | 2,491,488 | 818.00K |
| 464 | FLGT | Fulgent Genetics, Inc. | 553.61M | 1.36% | 337,286 | 323.93M |
| 465 | CTNM | Contineum Therapeutics, Inc. | 551.53M | -3.17% | 203,284 | - |
| 466 | DCTH | Delcath Systems, Inc. | 548.24M | -1.13% | 303,583 | 95.42M |
| 467 | EPRX | Eupraxia Pharmaceuticals Inc. | 528.45M | -0.74% | 260,309 | - |
| 468 | EOLS | Evolus, Inc. | 522.46M | -7.70% | 1,211,615 | 316.49M |
| 469 | AUTL | Autolus Therapeutics plc | 521.68M | -3.45% | 1,327,998 | 117.39M |
| 470 | ZURA | Zura Bio Limited | 515.56M | -5.78% | 1,150,873 | - |
| 471 | OVID | Ovid Therapeutics Inc. | 513.63M | -2.59% | 1,404,057 | 1.58M |
| 472 | ARTV | Artiva Biotherapeutics, Inc. | 509.44M | -3.43% | 449,473 | 251.00K |
| 473 | TCMD | Tactile Systems Technology, Inc. | 505.60M | 1.36% | 221,976 | 350.31M |
| 474 | IRD | Opus Genetics, Inc. | 505.00M | 5.93% | 6,536,928 | 9.86M |
| 475 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 476 | SPRY | ARS Pharmaceuticals, Inc. | 503.20M | -3.25% | 1,091,258 | 116.93M |
| 477 | EIKN | Eikon Therapeutics, Inc. | 498.86M | -14.17% | 665,062 | - |
| 478 | CERS | Cerus Corporation | 495.75M | -1.99% | 750,789 | 221.55M |
| 479 | ENTX | Entera Bio Ltd. | 483.07M | -1.76% | 437,509 | 42.00K |
| 480 | CAPR | Capricor Therapeutics, Inc. | 482.55M | -3.94% | 2,916,501 | 11.13M |
| 481 | PRLD | Prelude Therapeutics Incorporated | 480.99M | -8.25% | 562,116 | 22.42M |
| 482 | NPCE | NeuroPace, Inc. | 476.08M | -4.34% | 73,019 | 106.99M |
| 483 | PBYI | Puma Biotechnology, Inc. | 473.36M | 1.33% | 173,429 | 231.24M |
| 484 | EVH | Evolent Health, Inc. | 471.46M | 0.48% | 1,639,950 | 2.10B |
| 485 | NRC | NRC Health | 470.26M | 1.58% | 108,624 | 140.00M |
| 486 | KMDA | Kamada Ltd. | 464.78M | -2.68% | 110,224 | 191.85M |
| 487 | SENS | Senseonics Holdings, Inc. | 464.76M | 0.80% | 451,960 | 48.55M |
| 488 | CABA | Cabaletta Bio, Inc. | 464.55M | -5.84% | 7,077,177 | - |
| 489 | PRTA | Prothena Corporation plc | 463.06M | -3.01% | 310,810 | 54.53M |
| 490 | DNA | Ginkgo Bioworks Holdings, Inc. | 456.57M | -0.15% | 679,367 | 132.42M |
| 491 | KYTX | Kyverna Therapeutics, Inc. | 454.55M | -3.80% | 854,424 | - |
| 492 | SRTA | Strata Critical Medical, Inc. | 453.83M | -1.72% | 797,116 | 255.98M |
| 493 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 442.56M | -18.34% | 2,790,188 | - |
| 494 | SGHT | Sight Sciences, Inc. | 440.98M | -0.56% | 167,812 | 83.38M |
| 495 | RZLT | Rezolute, Inc. | 435.63M | 2.71% | 2,224,441 | - |
| 496 | RLMD | Relmada Therapeutics, Inc. | 434.15M | -0.49% | 2,808,958 | - |
| 497 | IKT | Inhibikase Therapeutics, Inc. | 424.23M | -3.32% | 332,362 | 1.00 |
| 498 | BNTC | Benitec Biopharma Inc. | 419.81M | -1.85% | 94,593 | - |
| 499 | CCCC | C4 Therapeutics, Inc. | 418.29M | -1.16% | 1,168,014 | 35.04M |
| 500 | VOGX | Vogenx, Inc. | 415.58M | 0.20% | 117,239 | - |